This inventor holds 2 USPTO granted patents. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovations of Mosè Santaniello
Introduction
Mosè Santaniello is a notable inventor based in Nettuno, Italy. He has made significant contributions to the field of pharmacology, particularly in the development of innovative compounds for medical applications. With a total of 2 patents, Santaniello's work has garnered attention in the pharmaceutical industry.
Latest Patents
Santaniello's latest patents include groundbreaking research on "Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds." This patent focuses on enhancing the delivery mechanisms of drugs within the body. Another significant patent is for "Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines." This invention describes non-hygroscopic salts of L-carnitine and lower alkanoyl L-carnitines with pamoic acid, which are utilized to create solid compositions for oral administration.
Career Highlights
Mosè Santaniello is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where he has been instrumental in advancing pharmaceutical innovations. His work has contributed to the development of new therapeutic options that improve patient outcomes.
Collaborations
Throughout his career, Santaniello has collaborated with esteemed colleagues, including Nazareno Scafetta and Maria Ornella Tinti. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Mosè Santaniello's contributions to the field of pharmacology through his patents and collaborations highlight his commitment to innovation in medicine. His work continues to influence the development of effective pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
